• Martin O Schmiady, Michael Hofmann, Juri Sromicki, Maximilian Halbe, Koen van Tilburg, Raed Aser, Carlos A Mestres, Francesco Maisano, and Enrico Ferrari.
• Division of Cardiac Surgery, University Heart Center, University Hospital of Zurich, Zurich, Switzerland.
• Interact Cardiovasc Thorac Surg. 2021 May 10; 32 (5): 812-816.

ObjectivesExtracorporeal membrane oxygenation (ECMO) is a resource-intensive, highly specialized and expensive therapy that is often reserved for high-volume centres. In recent years, we established an inter-hospital ECMO transfer programme that enables ECMO implants in peripheral hospitals. During the pandemic, the programme was expanded to include ECMO support in selected critically ill patients with coronavirus disease 2019 (COVID-19).MethodsThis retrospective single-centre study reports the technical details and challenges encountered during our initial experience with ECMO implants in peripheral hospitals for patients with COVID-19.ResultsDuring March and April 2020, our team at the University Hospital of Zurich performed 3 out-of-centre ECMO implants at different peripheral hospitals. The implants were performed without any complications. The patients were transported by ambulance or helicopter. Good preparation and selection of the required supplies are the keys to success. The implant should be performed by a well-trained, seasoned ECMO team, because options are limited in most peripheral hospitals.ConclusionsOut-of-centre ECMO implants in well-selected patients with COVID-19 is feasible and safe if a well-established organization is available and if the implantation is done by an experienced and regularly trained team.© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

19 keywords...

hide…